Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer

This study has been completed.
Information provided by (Responsible Party):
Dawn L. Hershman, Columbia University Identifier:
First received: June 3, 2008
Last updated: February 19, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)